Lampaso, Charito .

HRN: 28-70-86  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
CEFUROXIME 750MG (VIAL)
03/18/2026
03/25/2026
IV
750mg
Q8
S/p Orif
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines